After Failed Parkinson’s Trial, Sanofi Pauses Drug Development Programs
Source: Pixabay

After Failed Parkinson’s Trial, Sanofi Pauses Drug Development Programs

During clinical trials, researchers work to advance clinical knowledge, build an understanding of certain diseases or conditions, and learn more about a new drug, surgical device, or behavioral modification technology. However,…

Continue Reading After Failed Parkinson’s Trial, Sanofi Pauses Drug Development Programs